Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2018-2033)
2.2 Point of Care Diagnostics (POCD) Growth Trends by Region
2.2.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Point of Care Diagnostics (POCD) Historic Market Size by Region (2018-2023)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2024-2033)
2.3 Point of Care Diagnostics (POCD) Market Dynamics
2.3.1 Point of Care Diagnostics (POCD) Industry Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2018-2023)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2022
3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2024-2033)
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2018-2033)
6.2 North America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country (2018-2023)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2018-2033)
7.2 Europe Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country (2018-2023)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2018-2033)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2018-2033)
9.2 Latin America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2018-2023)
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2018-2033)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Detail
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Detail
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Detail
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Detail
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Detail
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Detail
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Detail
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.18.5 Abaxis Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
11.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.19.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Detail
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Detail
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Detail
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023)
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Blood Glucose Testing
Table 3. Key Players of Infectious Diseases Testing
Table 4. Key Players of Cardiac Markers Testing
Table 5. Key Players of Coagulation Testing
Table 6. Key Players of Pregnancy and Fertility Testing
Table 7. Key Players of Blood Gas/Electrolytes Testing
Table 8. Key Players of Tumor Markers Testing
Table 9. Key Players of Urinalysis Testing
Table 10. Key Players of Cholesterol Testing
Table 11. Key Players of Others
Table 12. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Point of Care Diagnostics (POCD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Point of Care Diagnostics (POCD) Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Point of Care Diagnostics (POCD) Market Share by Region (2018-2023)
Table 16. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Point of Care Diagnostics (POCD) Market Share by Region (2024-2033)
Table 18. Point of Care Diagnostics (POCD) Market Trends
Table 19. Point of Care Diagnostics (POCD) Market Drivers
Table 20. Point of Care Diagnostics (POCD) Market Challenges
Table 21. Point of Care Diagnostics (POCD) Market Restraints
Table 22. Global Point of Care Diagnostics (POCD) Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Point of Care Diagnostics (POCD) Market Share by Players (2018-2023)
Table 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2022)
Table 25. Ranking of Global Top Point of Care Diagnostics (POCD) Companies by Revenue (US$ Million) in 2022
Table 26. Global 5 Largest Players Market Share by Point of Care Diagnostics (POCD) Revenue (CR5 and HHI) & (2018-2023)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Point of Care Diagnostics (POCD) Product Solution and Service
Table 29. Date of Enter into Point of Care Diagnostics (POCD) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Point of Care Diagnostics (POCD) Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2018-2023)
Table 33. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2024-2033)
Table 35. Global Point of Care Diagnostics (POCD) Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2018-2023)
Table 37. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2024-2033)
Table 39. North America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Point of Care Diagnostics (POCD) Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Point of Care Diagnostics (POCD) Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Point of Care Diagnostics (POCD) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Point of Care Diagnostics (POCD) Market Size by Country (2024-2033) & (US$ Million)
Table 45. Asia-Pacific Point of Care Diagnostics (POCD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 46. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2018-2023) & (US$ Million)
Table 47. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2024-2033) & (US$ Million)
Table 48. Latin America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2018-2023) & (US$ Million)
Table 50. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2024-2033) & (US$ Million)
Table 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 52. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2018-2023) & (US$ Million)
Table 53. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2024-2033) & (US$ Million)
Table 54. Alere Company Detail
Table 55. Alere Business Overview
Table 56. Alere Point of Care Diagnostics (POCD) Product
Table 57. Alere Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 58. Alere Recent Development
Table 59. Roche Company Detail
Table 60. Roche Business Overview
Table 61. Roche Point of Care Diagnostics (POCD) Product
Table 62. Roche Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 63. Roche Recent Development
Table 64. Abbott Laboratories Company Detail
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Point of Care Diagnostics (POCD) Product
Table 67. Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Point of Care Diagnostics (POCD) Product
Table 72. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Siemens Healthcare Company Detail
Table 75. Siemens Healthcare Business Overview
Table 76. Siemens Healthcare Point of Care Diagnostics (POCD) Product
Table 77. Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 78. Siemens Healthcare Recent Development
Table 79. Danaher Company Detail
Table 80. Danaher Business Overview
Table 81. Danaher Point of Care Diagnostics (POCD) Product
Table 82. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 83. Danaher Recent Development
Table 84. QIAGEN Company Detail
Table 85. QIAGEN Business Overview
Table 86. QIAGEN Point of Care Diagnostics (POCD) Product
Table 87. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 88. QIAGEN Recent Development
Table 89. Bayer Healthcare Company Detail
Table 90. Bayer Healthcare Business Overview
Table 91. Bayer Healthcare Point of Care Diagnostics (POCD) Product
Table 92. Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 93. Bayer Healthcare Recent Development
Table 94. Beckman Coulter Company Detail
Table 95. Beckman Coulter Business Overview
Table 96. Beckman Coulter Point of Care Diagnostics (POCD) Product
Table 97. Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 98. Beckman Coulter Recent Development
Table 99. Nipro Diagnostics Company Detail
Table 100. Nipro Diagnostics Business Overview
Table 101. Nipro Diagnostics Point of Care Diagnostics (POCD) Product
Table 102. Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 103. Nipro Diagnostics Recent Development
Table 104. Bio-Rad Laboratories Company Detail
Table 105. Bio-Rad Laboratories Business Overview
Table 106. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product
Table 107. Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 108. Bio-Rad Laboratories Recent Development
Table 109. Nova Biomedical Company Detail
Table 110. Nova Biomedical Business Overview
Table 111. Nova Biomedical Point of Care Diagnostics (POCD) Product
Table 112. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 113. Nova Biomedical Recent Development
Table 114. BioMerieux Company Detail
Table 115. BioMerieux Business Overview
Table 116. BioMerieux Point of Care Diagnostics (POCD) Product
Table 117. BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 118. BioMerieux Recent Development
Table 119. Quidel Company Detail
Table 120. Quidel Business Overview
Table 121. Quidel Point of Care Diagnostics (POCD) Product
Table 122. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 123. Quidel Recent Development
Table 124. Helena Laboratories Company Detail
Table 125. Helena Laboratories Business Overview
Table 126. Helena Laboratories Point of Care Diagnostics (POCD) Product
Table 127. Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 128. Helena Laboratories Recent Development
Table 129. OraSure Technologies Company Detail
Table 130. OraSure Technologies Business Overview
Table 131. OraSure Technologies Point of Care Diagnostics (POCD) Product
Table 132. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 133. OraSure Technologies Recent Development
Table 134. Accriva Company Detail
Table 135. Accriva Business Overview
Table 136. Accriva Point of Care Diagnostics (POCD) Product
Table 137. Accriva Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 138. Accriva Recent Development
Table 139. Abaxis Company Detail
Table 140. Abaxis Business Overview
Table 141. Abaxis Point of Care Diagnostics (POCD) Product
Table 142. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 143. Abaxis Recent Development
Table 144. Chembio Diagnostics Company Detail
Table 145. Chembio Diagnostics Business Overview
Table 146. Chembio Diagnostics Point of Care Diagnostics (POCD) Product
Table 147. Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 148. Chembio Diagnostics Recent Development
Table 149. Trinity Biotech Company Detail
Table 150. Trinity Biotech Business Overview
Table 151. Trinity Biotech Point of Care Diagnostics (POCD) Product
Table 152. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 153. Trinity Biotech Recent Development
Table 154. Instrumentation Laboratory Company Detail
Table 155. Instrumentation Laboratory Business Overview
Table 156. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product
Table 157. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 158. Instrumentation Laboratory Recent Development
Table 159. Sekisui Diagnostics Company Detail
Table 160. Sekisui Diagnostics Business Overview
Table 161. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product
Table 162. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2018-2023) & (US$ Million)
Table 163. Sekisui Diagnostics Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Diagnostics (POCD) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Point of Care Diagnostics (POCD) Market Share by Type: 2022 VS 2033
Figure 3. Blood Glucose Testing Features
Figure 4. Infectious Diseases Testing Features
Figure 5. Cardiac Markers Testing Features
Figure 6. Coagulation Testing Features
Figure 7. Pregnancy and Fertility Testing Features
Figure 8. Blood Gas/Electrolytes Testing Features
Figure 9. Tumor Markers Testing Features
Figure 10. Urinalysis Testing Features
Figure 11. Cholesterol Testing Features
Figure 12. Others Features
Figure 13. Global Point of Care Diagnostics (POCD) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 14. Global Point of Care Diagnostics (POCD) Market Share by Application: 2022 VS 2033
Figure 15. Clinics Case Studies
Figure 16. Hospitals Case Studies
Figure 17. Assisted Living Healthcare Facilities Case Studies
Figure 18. Laboratory Case Studies
Figure 19. Point of Care Diagnostics (POCD) Report Years Considered
Figure 20. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Point of Care Diagnostics (POCD) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Region: 2022 VS 2033
Figure 23. Global Point of Care Diagnostics (POCD) Market Share by Players in 2022
Figure 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2022
Figure 26. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Point of Care Diagnostics (POCD) Market Share by Country (2018-2033)
Figure 28. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Point of Care Diagnostics (POCD) Market Share by Country (2018-2033)
Figure 32. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Region (2018-2033)
Figure 40. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Point of Care Diagnostics (POCD) Market Share by Country (2018-2033)
Figure 48. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Country (2018-2033)
Figure 52. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Alere Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 56. Abbott Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 58. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 59. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 60. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 61. Bayer Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 62. Beckman Coulter Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 63. Nipro Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 65. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 66. BioMerieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 67. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 68. Helena Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 69. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 70. Accriva Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 71. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 72. Chembio Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 73. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 74. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 75. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed